Synergistic effects of Deferasirox and Imatinib in chronic myeloid leukemia cells

被引：0
|
作者：
Kim, Dae Sik [1 ]
Kang, Myoung Hee [2 ]
Na, Yoo Jin [2 ]
Kim, Jung Lim [2 ]
Kim, Bo Ram [2 ]
Park, Kyong Hwa [1 ]
Oh, Sang Cheul [1 ]
Seo, Jae Hong [1 ]
Choi, Chul Won [1 ]
Kim, Jun Suk [1 ]
机构：
[1] Dept Internal Med, Div Oncol Hematol, Seoul, South Korea
[2] Korea Univ, Coll Med, Seoul, South Korea
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-5113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5113
引用
收藏
页数：1
相关论文
共 50 条
  • [41] APOPTOTIC EFFECTS OF RESVERATROL ON IMATINIB SENSITIVE AND RESISTANT K562 CHRONIC MYELOID LEUKEMIA CELLS
    Baran, Y.
    Can, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 351 - 352
  • [42] INFLUENCE OF TREATMENT WITH IMATINIB ON PURINERGIC SIGNALING IN CHRONIC MYELOID LEUKEMIA CELLS.
    Willig, J. B.
    Vianna, D. R. B.
    Beckenkamp, A.
    Beckenkamp, L. R.
    Gnoatto, S. C. B.
    Wink, M. R.
    Pilger, D. A.
    PURINERGIC SIGNALLING, 2018, 14 : S99 - S99
  • [43] IDENTIFICATION OF MICRORNA EXPRESSION CHANGES IN CHRONIC MYELOID LEUKEMIA CELLS IN RESPONSE TO IMATINIB
    Lin, H.
    Flamant, S.
    Jiang, X.
    EXPERIMENTAL HEMATOLOGY, 2011, 39 (08) : S90 - S91
  • [44] Imatinib derivatives as inhibitors of K562 cells in chronic myeloid leukemia
    Azevedo, Liviane D.
    Bastos, Monica M.
    Vasconcelos, Flavia C.
    Hoelz, Lucas V. B.
    Junior, Floriano P. S.
    Dantas, Rafael F.
    de Almeida, Ana C. M.
    de Oliveira, Andressa Paula
    Gomes, Larissa C.
    Maia, Raquel C.
    Boechat, Nubia
    MEDICINAL CHEMISTRY RESEARCH, 2017, 26 (11) : 2929 - 2941
  • [45] Synergistic Effects of Methotrexate and Suberoylanilide Hydroxamic Acid in Triggering Apoptosis of Chronic Myeloid Leukemia Cells
    Altundag, Ergul M.
    Yilmaz, Ayse M.
    Corek, Ceyda
    Yalcin, A. Suha
    Taga, Yavuz
    Kocturk, Semra
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2015, 25 (01): : 1 - 11
  • [46] Inhibition of Skp2 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib
    Chen, Xiaowen
    Huang, Zhenqi
    Wu, Wei
    Xia, Ruixiang
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 4777 - 4787
  • [47] Imatinib derivatives as inhibitors of K562 cells in chronic myeloid leukemia
    Liviane D. Azevedo
    Mônica M. Bastos
    Flávia C. Vasconcelos
    Lucas V. B. Hoelz
    Floriano P. S. Junior
    Rafael F. Dantas
    Ana C. M. de Almeida
    Andressa Paula de Oliveira
    Larissa C. Gomes
    Raquel C. Maia
    Nubia Boechat
    Medicinal Chemistry Research, 2017, 26 : 2929 - 2941
  • [48] ZFX Facilitates Cell Proliferation and Imatinib Resistance in Chronic Myeloid Leukemia Cells
    Jingjing Wu
    Bin Wei
    Qian Wang
    Yihan Ding
    Zhikui Deng
    Xueying Lu
    Yufeng Li
    Cell Biochemistry and Biophysics, 2016, 74 : 277 - 283
  • [49] Chromosomal abnormalities in chronic myeloid leukemia: Evidence of a hierarchy in imatinib treated cells
    Ostro, D.
    Cheung, K.
    Kamel-Reid, S.
    Lipton, J. H.
    LEUKEMIA & LYMPHOMA, 2007, 48 (05) : 1029 - 1031
  • [50] Enhanced induction of apoptosis in chronic myeloid leukemia cells through synergistic effect of telomerase inhibitor MST-312 and imatinib
    Karami, Najibe
    Navidinia, Amir Abbas
    Ehsan, Mohsen
    Farsinejad, Alireza
    Fatemi, Ahmad
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
12345